Treatment Strategy for Long COVID Based on Traditional Chinese Medicine
- PMID: 40395923
- PMCID: PMC12086455
- DOI: 10.14789/ejmj.JMJ24-0041-P
Treatment Strategy for Long COVID Based on Traditional Chinese Medicine
Abstract
Post-acute COVID-19 conditions, commonly known as 'long COVID', occur in individuals with a history of probable or confirmed severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infection, typically 3 months from the onset of COVID-19 with symptoms, lasting for at least 2 months, that cannot be explained by any alternative diagnoses. Although most symptoms improve over time, some patients experience significant limitations in their social lives. Under such circumstances, complementary and alternative medicine (CAM) interventions are growing in popularity as possible treatments for long COVID symptoms. There are a wide variety of CAM interventions, such as traditional Japanese medicine (Kampo medicine) and traditional Chinese medicine (TCM). In this study, we compared three studies using Kampo medicine with those using TCM and concluded that Kampo medicine, which is often practiced in Japan due to its historical background, may have some limitations in managing the diverse symptoms of long COVID because the symptoms of long COVID vary widely. Therefore, we propose that medical examinations based on TCM should also be considered as an alternative treatment strategy for patients with long COVID.
Keywords: Kampo medicine; complementary and alternative medicine; long COVID; traditional Chinese herbal medicine; traditional Chinese medicine.
© 2025 The Juntendo Medical Society.
Conflict of interest statement
MN receive lecture fee from Tsumura & Co.
Similar articles
-
A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.Trials. 2020 Oct 2;21(1):827. doi: 10.1186/s13063-020-04746-9. Trials. 2020. PMID: 33008479 Free PMC article.
-
Traditional Chinese medicine and Kampo: a review from the distant past for the future.J Int Med Res. 2006 May-Jun;34(3):231-9. doi: 10.1177/147323000603400301. J Int Med Res. 2006. PMID: 16866016 Review.
-
Treatment of Long Coronavirus Disease in Japan: A Nationwide Study of Symptom-Associated Drug Prescriptions.Biol Pharm Bull. 2025;48(5):641-649. doi: 10.1248/bpb.b24-00762. Biol Pharm Bull. 2025. PMID: 40383636
-
A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).Trials. 2021 Jan 6;22(1):23. doi: 10.1186/s13063-020-04939-2. Trials. 2021. PMID: 33407828 Free PMC article.
-
Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19.Front Med. 2023 Dec;17(6):1014-1029. doi: 10.1007/s11684-023-1040-8. Epub 2023 Dec 29. Front Med. 2023. PMID: 38157191 Review.
References
-
- World Health Organization: A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_cond... (Last accessed Dec 24, 2024)
-
- Harris E: WHO Declares End of COVID-19 Global Health Emergency. JAMA, 2023; 329: 1817. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous